Abstract Background Extracorporeal membrane oxygenation (ECMO) was frequently used to treat patients with severe coronavirus disease‑2019 (COVID‑19)‑associated acute respiratory distress (ARDS) during the initial outbreak. Care of COVID‑19 patients evolved..
Read More
Abstract Purpose: Invasive pulmonary aspergillosis (IPA) is increasingly reported in patients with severe coronavirus disease 2019 (COVID‑19) admitted to the intensive care unit (ICU). Diagnosis and management of COVID‑19 associated..
Read More
Abstract Purpose: Extracorporeal membrane oxygenation (ECMO) use for severe coronavirus disease 2019 (COVID‑19) patients has increased during the course of the pandemic. As uncertainty existed regarding patient’s outcomes, early guidelines..
Read More
Abstract Objective The coronavirus disease (COVID‐19) increases the respiratory complications and carries a higher mortality in the immediate postoperative period. The aim of this study was to analyze the outcomes..
Read More
Abstract Background The coronavirus disease 2019 (COVID‐19) pandemic poses broad challenges to healthcare systems and providers. The manifestations of this disease are still being described in a variety of different..
Read More
Abstract Despite advances in medical technology, the mortality rate for severe acute respiratory distress syndrome (ARDS) remains high at around 40% []. In recent years, multiple studies, systematic reviews, and..
Read More
Abstract Both antiviral treatment with remdesivir and hemoadsorption using a CytoSorb® adsorption device are applied in the treatment of severe COVID‐19. The CytoSorb® adsorber consists of porous polymer beads that adsorb a..
Read More
Abstract Extracorporeal life support (ECLS) is a means to support patients with acute respiratory failure. Initially, recommendations to treat severe cases of pandemic coronavirus disease 2019 (COVID‐19) with ECLS have..
Read More
This case reports on a 13-year-old male patient who presented to hospital with fever (38.9°), reduced general condition, vomiting and pain in his limbs. [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/02/Use-of-CytoSorb-in-a-pediatric-patient-with-severe-rhabdomyolysis-in-the-context-of-a-SARS-CoV-2-infection_compressed.pdf" title="Use of CytoSorb..
Read More
This case reports on a 31-year-old male patient with no significant medical history, who was hospitalized following several days of non-quantified fever associated with odynophagia. [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/02/Use-of-CytoSorb-in-a-patient-with-severe-COVID-19_compressed.pdf" title="Use of..
Read More
Limited treatment options are currently available for critically-ill COVID-19 ICU patients who may experience mortality rates up to 50%. [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/02/CytoSorb-Therapy-Manage-cytokine-storm-in-patients-with-COVID-19_compressed.pdf" title="CytoSorb Therapy Manage cytokine storm in patients with..
Read More
Actualmente se dispone de opciones de tratamiento limitadas para pacientes graves de COVID-19 en UCI, pudiendo alcanzar tasas de mortalidad de hasta el 50 %. [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/02/cytosorb-covid19_compressed.pdf" title="cytosorb covid19_compressed"]
Read More
Abstract As New York State quickly became the epicenter of the COVID-19 pandemic, innovative strategies to provide care for the COVID-19 negative patients with urgent or immediately life threatening cardiovascular..
Read More
Despite the critical role of cytokines in the modulation of the immune response, cytokine hyperactivity has been implicated in the pathogenesis of severe organ failure secondary to sepsis, cardiac surgery,..
Read More
Abstract Introduction Coronavirus disease 2019 (COVID‐19) is a contagious disease that is caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). Health care workers are at risk of infection..
Read More